Total Payments
$24,376
2024 Payments
$19,044
Companies
34
Transactions
452
Medicare Patients
2,160
Medicare Billing
$260,463

Payment Breakdown by Category

Other$13,350 (54.8%)
Food & Beverage$10,889 (44.7%)
Travel$121.27 (0.5%)
Education$15.27 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,350 6 54.8%
Food and Beverage $10,889 442 44.7%
Travel and Lodging $121.27 3 0.5%
Education $15.27 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $14,633 33 $0 (2024)
ABBVIE INC. $2,166 95 $0 (2024)
GENZYME CORPORATION $1,286 31 $0 (2024)
Regeneron Healthcare Solutions, Inc. $687.04 20 $0 (2024)
UCB, Inc. $683.61 69 $0 (2024)
Janssen Biotech, Inc. $572.18 23 $0 (2024)
LEO Pharma Inc. $566.11 23 $0 (2024)
E.R. Squibb & Sons, L.L.C. $553.17 20 $0 (2024)
Lilly USA, LLC $480.95 18 $0 (2024)
PFIZER INC. $396.80 32 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $19,044 216 Amgen Inc. ($14,396)
2023 $3,199 156 ABBVIE INC. ($682.12)
2022 $1,630 69 ABBVIE INC. ($477.50)
2021 $130.60 6 AbbVie Inc. ($35.14)
2020 $137.20 3 AbbVie Inc. ($137.20)
2019 $112.49 1 Galderma Laboratories, L.P. ($112.49)
2018 $122.52 1 Regeneron Healthcare Solutions, Inc. ($122.52)

All Payment Transactions

452 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/27/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $31.15 General
Category: Immunology
12/26/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
Category: Inflammation
12/26/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $600.00 General
Category: Inflammation
12/23/2024 Amgen Inc. Otezla (Drug) Travel and Lodging Cash or cash equivalent $48.24 General
Category: Inflammation
12/18/2024 Lilly USA, LLC TALTZ (Drug), EBGLYSS Food and Beverage In-kind items and services $26.15 General
Category: Immunology
12/18/2024 LEO Pharma Inc. ADBRY (Biological) Food and Beverage In-kind items and services $23.84 General
Category: DERMATOLOGY
12/18/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $13.10 General
Category: Immunology
12/18/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $2.89 General
Category: Immunology
12/18/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $1.16 General
Category: Immunology
12/17/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $142.76 General
Category: Inflammation
12/17/2024 Amgen Inc. Otezla (Drug) Travel and Lodging Cash or cash equivalent $48.24 General
Category: Inflammation
12/16/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $86.62 General
Category: Immunology
12/16/2024 PFIZER INC. CIBINQO (Drug), LITFULO Food and Beverage In-kind items and services $16.33 General
Category: Inflammation & Immunology
12/12/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $9.27 General
Category: Immunology
12/12/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $2.73 General
Category: Immunology
12/12/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $1.59 General
Category: Immunology
12/12/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $0.36 General
Category: Immunology
12/10/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $46.89 General
Category: Immunology
12/06/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $23.66 General
Category: Immunology
12/05/2024 Novartis Pharmaceuticals Corporation COSENTYX (Drug) Food and Beverage In-kind items and services $28.33 General
Category: Dermatology
12/02/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $19.51 General
Category: Inflammation
12/02/2024 Arcutis Biotherapeutics, Inc. Zoryve (Drug) Food and Beverage In-kind items and services $13.51 General
Category: Dermatology
11/22/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $20.60 General
11/21/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $29.59 General
Category: Dermatology
11/19/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 22 2,160 10,197 $631,176 $260,463
Total Patients
2,160
Total Services
10,197
Medicare Billing
$260,463
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 401 678 $87,401 $50,080 57.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 220 331 $63,299 $33,982 53.7%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 136 199 $91,270 $29,103 31.9%
17110 Destruction of skin growth, 1-14 growths Office 2023 207 289 $52,435 $28,450 54.3%
17000 Destruction of precancer skin growth, 1 growth Office 2023 340 483 $71,987 $21,163 29.4%
11102 Biopsy of related skin growth, first growth Office 2023 190 228 $40,140 $17,183 42.8%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 287 1,970 $68,649 $12,030 17.5%
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm Office 2023 22 28 $21,650 $10,401 48.0%
96574 Application of light with debridement to destroy precancer skin growth Office 2023 29 40 $18,483 $10,212 55.3%
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg Office 2023 21 5,600 $16,630 $6,947 41.8%
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm Office 2023 13 15 $16,008 $6,319 39.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 57 57 $10,920 $5,005 45.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 38 38 $11,240 $4,941 44.0%
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm Office 2023 32 40 $17,811 $4,392 24.7%
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm Office 2023 16 16 $8,955 $4,318 48.2%
13101 Complicated repair of wound of trunk, 2.6-7.5 cm Office 2023 11 12 $8,620 $4,298 49.9%
11103 Biopsy of related skin growth, each additional growth Office 2023 56 76 $7,238 $3,469 47.9%
11104 Punch biopsy, first skin growth Office 2023 20 21 $4,662 $2,408 51.7%
11622 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm Office 2023 13 15 $7,047 $1,698 24.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 28 32 $2,506 $1,544 61.6%
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less Office 2023 12 17 $2,169 $1,301 60.0%
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm Office 2023 11 12 $2,053 $1,221 59.5%

About Dr. Benjamin Farahnik, MD

Dr. Benjamin Farahnik, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2017. The National Provider Identifier (NPI) number assigned to this provider is 1699209254.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Farahnik, MD has received a total of $24,376 in payments from pharmaceutical and medical device companies, with $19,044 received in 2024. These payments were reported across 452 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,350).

As a Medicare-enrolled provider, Farahnik has provided services to 2,160 Medicare beneficiaries, totaling 10,197 services with total Medicare billing of $260,463. Data is available for 1 year (2023–2023), covering 22 distinct procedure/service records.

Practice Information

Products in Payments

  • Otezla (Drug) $14,604
  • DUPIXENT (Biological) $1,722
  • SKYRIZI (Biological) $912.04
  • RINVOQ (Biological) $834.92
  • ADBRY (Biological) $566.11
  • Sotyktu (Drug) $553.17
  • TREMFYA (Drug) $529.02
  • TALTZ (Drug) $405.95
  • Bimzelx (Biological) $365.95
  • COSENTYX (Drug) $323.51
  • OPZELURA (Drug) $251.28
  • EUCRISA (Drug) $216.15
  • Cimzia (Drug) $185.12
  • CIBINQO (Drug) $180.65
  • SPEVIGO (Drug) $170.27
  • HUMIRA (Biological) $150.04
  • VTAMA (Drug) $135.50
  • LIBTAYO (Biological) $128.27
  • DUPIXENT DUPILUMAB INJECTION (Biological) $122.52
  • EPIDUO FORTE (Drug) $112.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Long Beach